Ali Bin Ali Medical enjoys a family day out

The Ali Bin Ali Medical team took time out of their busy schedules to enjoy a day of fun with their families. The event was organized on March 12, 2022, at Retaj Salwa Resort.

All ABA Medical staff members and their families attended the event, where a full range of fun activities were arranged for their entertainment. The organizers ensured that there were activities for all age groups and all guests enjoyed the day.

Fun and entertainment activities included game stations, trivia competition, talent shows, kids’ activities and karaoke. An exciting raffle draw added excitement to the already eventful day. ABA Medical also took this opportunity to recognize the contribution of its employees. Awards, certificates and trophies were handed out for long service and outstanding & excellent performances.

The elaborate lunch menu was a crowd-pleaser and everybody enjoyed it.

Speaking about the gathering, General Manager of ABA Medical Mr. Monzer Abdel Samad said: “It was a well-deserved break for the entire ABA Medical team. It was good to see everyone enjoying with their family and colleagues. This was also an ideal occasion to casually socialize with the team members away from the work pressure and deadlines. Overall, it was a different kind of a productive day.”

 

Ali Bin Ali Medical signs strategic partnership with Elegancia Healthcare

Expanding its already impressive portfolio, Ali Bin Ali Medical signed a strategic partnership with Elegancia Healthcare, operator of The View Hospital, on November 1, 2021.

The signing ceremony was hosted in Lusail at the headquarters of Elegancia Healthcare. Under the agreement, Ali Bin Ali Medical will supply state-of-the-art radiology equipment to The View Hospital, Doha’s newest and most advanced healthcare facility.

Located in Doha’s prestigious Al Qutaifiya area, in the vicinity of Lusail, Katara and The Pearl-Qatar, The View Hospital is scheduled to open in the fourth quarter of 2022. The commercial agreement is in line with Ali Bin Ali Medical’s commitment to support the government’s Qatar National Vision 2030 to promote high-quality, sustainable healthcare.

The partnership also once again proves Ali Bin Ali Medical to be a favored ‘partner of choice’ for all stakeholders in the healthcare industry in order to provide the best-in-class products, services and solutions and support in enhancing the healthcare sector in Qatar.

The agreement was signed by UCC, the main contractor of The View Hospital, represented by Mohamad Sabri, Group CEO of UCC Holding, and Ali Bin Ali Medical, represented by Monzer Abdel Samad, General Manager of Ali Bin Ali Medical, in the presence of Mr. Nabeel Ali Bin Ali, Vice-Chairman and EVP of Ali Bin Ali Holding, and Mr. Moutaz Al Khayyat, Chairman of both UCC Holding and Elegancia Group.

Also present at the event representing the Siemens team, who are partners with Ali Bin Ali Medical, was Yousef Saleh – Country Lead. The signing ceremony was also attended by Henrik Christiansen, Group CEO of Elegancia, and Bassam Sayad, Cluster CEO of Elegancia Healthcare.

Nabeel Ali Bin Ali, Vice-Chairman and Executive Vice President of Ali Bin Ali Holding, said: “Ali Bin Ali Medical is glad to welcome this new partnership. We are committed to providing state-of-the-art medical services and get the best technology for the people of Qatar. Our vision is aligned with Qatar National Vision 2030 and we aim to create a world-class healthcare system that is sustainable and accessible to the whole population.”

Ramez Al Khayyat, Vice-Chairman and Group CEO of Power International Holding, said: “The View Hospital will set new standards for quality and innovation in patient care. Working with Ali Bin Ali Medical, we will put cutting-edge technology at the heart of healthcare provision, helping improve patient outcomes and experience. The View will be nothing less than transformative for the healthcare sector in Qatar.”

ABA Group’s QCare Medical announces signing of exclusive agreement with Endocare USA

Fulfilling its promise to introduce state-of-the-art services from international medical brands to the Qatari market, Ali Bin Ali (ABA) Group’s QCare Medical announced the signing of an exclusive agreement with Endocare Inc. USA for the distribution of its Endocare™ Cryoablation technology in Qatar.

A prime vision of ABA Group has been to create a comprehensive, world-class healthcare system in Qatar, whose services are accessible to the whole population.

Keeping this vision in mind and with the aim of complying with the Qatar National Health Strategy (NHS) 2017-2022, QCare in May 2017 proudly installed the first Endocare™ cryoablation machine – Cryocare Cs – in the Middle East at Hamad General Hospital.

Well known Urologist Dr. Franco Lugnani flew in to Doha to conduct a demonstration and training for the medical teams of Dr. Ahmed Omar, Head of Radiology department & Dr. Khalid Al Rumaihi, Head of Urology department at Hamad General Hospital. On May 25, the team performed 3 successful surgeries with the Cryocare Cs .

Speaking about this strategic agreement, Mr. Zuhdi Z Al-Jaouni, General Manager of Qcare Medical & ABA Medical, said: “This exclusive agreement is a particularly important one as a growing amount of evidence supports the use of cryotherapy for patients with localized prostate cancer following radiation therapy.”

Endocare Inc. is a medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation.

Endocare™ cryoablation therapy focuses on the development of a specialized type of cryotherapy for the minimally invasive treatment of cancer with a faster and easier-to-operate cryoablation system for freezing cancerous tumors and tissue.

Endocare remains the market leader in this category, as this new system uses nitrogen as the freezing and tumor-destroying element. The nitrogen, called “critical nitrogen” because it works in a unique form at the critical point where gas nearly becomes liquid, is also more powerful and readily available in surgical suites than argon, the freezing element in Endocare’s current market-leading cryoablation systems.